CS logo
small CS logo
MAGODENT Sp. z o.o. Szpital Elblaska

Warszawa, Poland
Hospital in Warsaw
Szamocka 6, 01-748 Warszawa

About MAGODENT Sp. z o.o. Szpital Elblaska


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at MAGODENT Sp. z o.o. Szpital Elblaska


During the past decade, MAGODENT Sp. z o.o. Szpital Elblaska conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "MAGODENT Sp. z o.o. Szpital Elblaska" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at MAGODENT Sp. z o.o. Szpital Elblaska


According to Clinical.Site data, the most researched conditions in "MAGODENT Sp. z o.o. Szpital Elblaska" are "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "MAGODENT Sp. z o.o. Szpital Elblaska" in a lesser frequency.

Clinical Trials Intervention Types at MAGODENT Sp. z o.o. Szpital Elblaska


Most popular intervention types in "MAGODENT Sp. z o.o. Szpital Elblaska" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "Binimetinib" (1 trials), "Cetuximab" (1 trials), "Encorafenib" (1 trials) and "Folinic Acid" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MAGODENT Sp. z o.o. Szpital Elblaska


The vast majority of trials in "MAGODENT Sp. z o.o. Szpital Elblaska" are 2 trials for "All" genders.

Clinical Trials Status at MAGODENT Sp. z o.o. Szpital Elblaska


Currently, there are NaN active trials in "MAGODENT Sp. z o.o. Szpital Elblaska". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MAGODENT Sp. z o.o. Szpital Elblaska, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MAGODENT Sp. z o.o. Szpital Elblaska, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".